Moreover, clinical results indicated that the transcript levels of YES1 and YAP are higher in colon cancer patients with liver metastases after 5FU-based neoadjuvant chemotherapy, which was also positively correlated with colon cancer recurrence and shorter patient survival [41]. This evidence concerns the gene YES1 and malignant colon neoplasm.